Abstract:Liangliang Ma, 1 Maolong Gao 2 1 Department of Infectious Diseases, Beijing Geriatric Hospital, Beijing, 100095, People's Republic of China; 2 Department of Science and Technology, Beijing Geriatric Hospital, Beijing, 100095, People's Republic of China Correspondence: Liangliang Ma, Department of Infective Diseases, Beijing Geriatric Hospital, No. 118 Wenquan Road, Haidian District, Beijing, 100095, People's Republic of China, Tel +86-18610672953, Email Objective: To analyze the clinical characteristics and risk factors of drug resistance of newly-treated chronic obstructive pulmonary disease (COPD) complicated pulmonary tuberculosis (PTB). Methods: A total of 489 newly-treated PTB patients admitted to Beijing Geriatric hospital were retrospectively enrolled in this study. Of these, 138 patients with COPD were allocated to the study group, and the remaining 351 patients without COPD were allocated to the control group. The baseline information, clinical characteristics of PTB and drug resistance of Mycobacterium tuberculosis were compared between the two groups. Logistic regression was used to explore the correlation between drug resistance and COPD complications. Results: Patients complicated with COPD had a higher proportion of respiratory failure, cough, fever and night sweats, chest short breath, and emaciation between the study group and the control group ( P < 0.05). In terms of medical history, patients complicated with COPD also had a higher proportion of childhood TB history, cough, tuberculosis exposure rate, dust exposure rate, and malnutrition ( P < 0.05). There were significantly more patients with pulmonary cavities and a delayed diagnosis of TB in the study group than in the control group ( P < 0.05). The single drug resistance rates of isoniazid, ethambutol, rifampicin, pyrazinamide, and rifapentine, and drug resistance with any two or more drugs in the study group were significantly higher than those in the control group ( P < 0.05). Multivariate Logistic regression analysis showed that smoking, extrapulmonary tuberculosis, tuberculosis exposure history, malnutrition, pulmonary cavity, and delayed TB diagnosis were risk factors for drug resistance in newly-treated COPD complicated PTB patients. Conclusion: The symptoms of COPD complicated PTB were more serious. Smoking history, extrapulmonary tuberculosis, tuberculosis exposure history, malnutrition, pulmonary cavity, and delayed diagnosis of tuberculosis were risk factors for TB resistance in these patients. Keywords: chronic obstructive pulmonary disease, pulmonary tuberculosis, Mycobacterium tuberculosis , drug resistance, risk factors Tuberculosis (TB) is a common infectious disease in the world, mainly caused by Mycobacterium tuberculosis . TB has a strong infectivity and high prevalence with severe mortality. 1 According to the 2019 Global TB Report, there were about 10 million new cases in 2018 all over the world, and China was one of the 30 countries with a high TB burden, accounting for 14% of them. 2 The rate of multi-drug-resistant tuberculosis (MDR-TB) in China was 6.8%, with an estimated 339,000 incident cases among the population over 15 years old in 2010. 3 Previous studies showed that TB was an important risk factor for chronic obstructive pulmonary disease (COPD). 4 At the same time, COPD was also closely related to tuberculosis. 5 At present, about 9.9% of people older than 40 years in China are suffering from COPD, and the number of COPD patients is increasing with ages and environmental pollution. 6 Besides, COPD is also an important cause of Mycobacterium tuberculosis drug resistance. 7 Compared with TB alone patients, those with COPD combined TB face more severe health threats. Patients with COPD complicated pulmonary tuberculosis (PTB) often have a poor prognosis if they could not get suitable treatment in time. In addition, the cure rate of drug-resistant TB is extremely low. 8 Drug resistance of TB bacilli increases the difficulty of treatment and the cost of patients, which brings more barriers to the treatment and prevention of TB. Therefore, it is necessary to analyze the clinical characteristics of COPD complicated PTB. The aim of this study was to analyze the clinical characteristics of newly-treated COPD complicated PTB patients, and the risk factors of Mycobacterium tuberculosis drug resistance, so as to provide reference for clinical practice. This study retrospectively included 489 cases of newly-treated PTB patients admitted to Beijing Geriatric hospital from October 2019 to October 2021. They were divided into a PTB (35 -Abstract Truncated-

Analysis of Clinical Characteristics and Risk Factors for Drug Resistance in Newly-Treated Patients with Pulmonary Tuberculosis Complicated with Chronic Obstructive Pulmonary Disease